The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and financial implications of ADUARA trial on a real-world population.
 
Bharathi Muthusamy
No Relationships to Disclose
 
Emily Craig Zabor
No Relationships to Disclose
 
Nathan A. Pennell
Consulting or Advisory Role - Anheart Therapeutics; Bayer; Genentech; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Novartis; Pfizer; ResistanceBio; Sanofi/Regeneron; Summit Therapeutics; Takeda; Vial
Research Funding - Anheart Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Loxo (Inst); Merck (Inst); Mirati Therapeutics (Inst); Navire (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst)